Cargando…

Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials

Oral emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) has been evaluated as pre-exposure prophylaxis (PrEP). We describe the accuracy of self-reported adherence to FTC/TDF and pill counts when compared to drug concentrations in the FEM-PrEP trial. Using drug concentrations of plasma tenofovir (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agot, Kawango, Taylor, Douglas, Corneli, Amy L., Wang, Meng, Ambia, Julie, Kashuba, Angela D. M., Parker, Caleb, Lemons, Ansley, Malahleha, Mookho, Lombaard, Johan, Van Damme, Lut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415940/ https://www.ncbi.nlm.nih.gov/pubmed/25100053 http://dx.doi.org/10.1007/s10461-014-0859-z

Ejemplares similares

Facilitators of Adherence to the Study Pill in the FEM-PrEP Clinical Trial
por: Corneli, Amy, et al.
Publicado: (2015)

The Sexual Risk Context among the FEM-PrEP Study Population in Bondo, Kenya and Pretoria, South Africa
por: Headley, Jennifer, et al.
Publicado: (2014)

FEM-PrEP: Adherence Patterns and Factors Associated With Adherence to a Daily Oral Study Product for Pre-exposure Prophylaxis
por: Corneli, Amy L., et al.
Publicado: (2014)

Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report
por: Malahleha, Mookho, et al.
Publicado: (2015)

Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial()()
por: Nanda, Kavita, et al.
Publicado: (2016)

Preparing for the Rollout of Pre-Exposure Prophylaxis (PrEP): A Vignette Survey to Identify Intended Sexual Behaviors among Women in Kenya and South Africa if Using PrEP
por: Corneli, Amy, et al.
Publicado: (2015)

A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa
por: Corneli, Amy L, et al.
Publicado: (2014)

Neurological syndrome in an HIV-prevention trial participant randomized to daily tenofovir disoproxil fumarate (300 mg) and emtricitabine (200 mg) in Bondo, Kenya
por: Owino, Fredrick, et al.
Publicado: (2013)

Integrating oral PrEP delivery among African women in a large HIV endpoint‐driven clinical trial
por: Beesham, Ivana, et al.
Publicado: (2020)

The importance of PrEP persistence in preventing HIV infections on PrEP
por: Spinelli, Matthew A, et al.
Publicado: (2020)

“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women
por: Pasipanodya, Elizabeth C., et al.
Publicado: (2021)

PrEP-RN: Clinical Considerations and Protocols for Nurse-Led PrEP
por: O'Byrne, Patrick, et al.
Publicado: (2019)

1287. PrEP-Engaged or PrEP Curious?: A Characterization and Comparison of Initial PrEP Appointment Attenders vs. Nonattenders
por: Kahal, Deborah A, et al.
Publicado: (2019)

Predictors of PrEP awareness, PrEP discussion and interest in long‐acting injectable PrEP among Filipina transfeminine adults
por: Restar, Arjee Javellana, et al.
Publicado: (2023)

Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial
por: Mandala, Justin, et al.
Publicado: (2014)

PrEP and the syndemic of substance use, violence, and HIV among female and male sex workers: a qualitative study in Kisumu, Kenya
por: Bazzi, Angela R, et al.
Publicado: (2019)

Slow Uptake of PrEP: Behavioral Predictors and the Influence of Price on PrEP Uptake Among MSM with a High Interest in PrEP
por: van Dijk, Mart, et al.
Publicado: (2021)

Efficiency in PrEP Delivery: Estimating the Annual Costs of Oral PrEP in Zimbabwe
por: Mangenah, Collin, et al.
Publicado: (2021)

PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV
por: Hill, Kristi C, et al.
Publicado: (2022)

Complex PrEP: the factors requiring consultant-led review of PrEP users
por: Tittle, Victoria, et al.
Publicado: (2022)

Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: Results of a consultation with community stakeholders
por: Mack, Natasha, et al.
Publicado: (2014)

“You can’t have a PrEP program without a PrEP Coordinator”: Implementation of a PrEP panel management intervention
por: Saberi, Parya, et al.
Publicado: (2020)

PrEP implementation: moving from trials to policy and practice
por: Cáceres, Carlos F, et al.
Publicado: (2015)

981. Extended Adherence and Persistence to HIV PrEP in a Multidisciplinary PrEP Clinic
por: Whelchel, Kristen, et al.
Publicado: (2020)

Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP
por: Celum, Connie, et al.
Publicado: (2023)

Study protocol for an efficacy trial of the “PrEP for Health” intervention to increase HIV PrEP use among people who inject drugs
por: Bazzi, Angela R., et al.
Publicado: (2023)

Patterns of PrEP continuation and coverage in the first year of use: a latent class analysis of a programmatic PrEP trial in Kenya
por: Mugwanya, Kenneth K., et al.
Publicado: (2023)

“Yes, I’m interested in taking PrEP!”: PrEP interest among women respondents to the European community-based survey “Flash! PrEP in Europe”
por: Delabre, Rosemary M., et al.
Publicado: (2021)

Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study
por: Amico, K. Rivet, et al.
Publicado: (2016)

52. PrEP Adherence and Discontinuation at a Pharmacy-Supported PrEP Program in Atlanta, GA
por: Yacout, Hiba, et al.
Publicado: (2021)

Understanding the Association between PrEP Stigma and PrEP Cascade Moderated by the Intensity of HIV Testing
por: Zhang, Chen, et al.
Publicado: (2022)

PrEP Acceptance among Eligible Patients Attending the Largest PrEP Clinic in Jackson, Mississippi
por: Hollcroft, Madison R., et al.
Publicado: (2023)

Assessing the Impact of a PrEP Aware Week Campaign on PrEP Prescription Fills in NYS
por: Tesoriero, James M., et al.
Publicado: (2022)

Perceptions, motivations, and beliefs about HIV risk and pre-exposure prophylaxis (PrEP) among participants in a nurse-led PrEP service (PrEP-RN)
por: Orser, Lauren, et al.
Publicado: (2022)

How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP
por: Pilkington, Victoria, et al.
Publicado: (2018)

PrEP: controversy, agency and ownership
por: Cairns, Gus P, et al.
Publicado: (2016)

Pathopolitics: Pathologies and Biopolitics of PrEP
por: Atuk, Tankut
Publicado: (2020)

Navigating the Intersection of PrEP and Medicaid
por: Seiler, Naomi, et al.
Publicado: (2022)

Seasonal PrEP for partners of migrant miners in southern Mozambique: a highly focused PrEP intervention
por: Cremin, Ide, et al.
Publicado: (2015)

Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda
por: Muwonge, Timothy R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d79t7uo9quuc1phjplr795nbit